ANVS: Annovis Bio, Inc. Stock

by  •  • Comments Off on ANVS: Annovis Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 51.44
Enterprise Value ($M) 29.21
Book Value ($M) 24.05
Book Value / Share 1.23
Price / Book 2.14
NCAV ($M) 24.05
NCAV / Share 1.23
Price / NCAV 2.14

Profitability (mra)
Return on Invested Capital (ROIC) -1.21
Return on Assets (ROA) -3.72
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 10.68
Current Ratio 10.68

Balance Sheet (mrq) ($M)
Current Assets 26.74
Assets 26.74
Liabilities 2.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -26.69
Net Income -24.59
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -21.89
Cash from Investing 0.00
Cash from Financing 26.69

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-12 13G/A CVI Investments, Inc. 4.90 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 129,950 350,722 37.05
2025-05-30 90,869 224,003 40.57
2025-05-29 185,953 697,783 26.65
2025-05-28 332,273 1,419,203 23.41

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA
ANRO – Alto Neuroscience, Inc. BHC – Bausch Health Companies Inc.
BHVN – Biohaven Ltd.


Financial data and stock pages provided by
Fintel.io